<DOC>
	<DOCNO>NCT02647164</DOCNO>
	<brief_summary>The purpose study ass value circulate tumor cell ( CTC ) non-small cell lung cancer postoperative recurrence monitoring compare CTCs , CT tumor marker different time points.The time CTC carcinoembryonic antigen ( CEA ) detection baseline , 2~7 day , 3 month , 6 month , 12 month , 24 month , 36 month surgery . And time CT detection 6 month , 12 month , 24 month , 36 month surgery .</brief_summary>
	<brief_title>The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<criteria>Age 1880 year old Patients histologically document ( stage Ⅰ/Ⅱ/ⅢA ) nonsmall cell lung cancer . Patients undergo surgery . Patients preoperative CTCs ≥8.5 Units / 3 ml Informed consent must obtain patient prior begin therapy . Patients ability understand willingness sign write informed consent document . Patients histologically document ( stage Ⅰ/Ⅱ/ⅢA ) nonsmall cell lung cancer . After operation review , patient ' result CTC , CT tumor marker incomplete point . The blood sample n't collect predetermined time . The blood sample appear hemolysis . The blood sample n't enough .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Non-small-cell lung carcinoma</keyword>
	<keyword>Circulating tumor cell</keyword>
</DOC>